https://doi.org/10.4081/ejtm.2022.10169
Anti-inflammatory activity of a natural herbal-marine drug (MS14 - SANT and SUSP) compared to sodium salicylate or methylprednisolone in a rat model for multiple sclerosis
Submitted: 5 October 2021
Accepted: 6 November 2021
Published: 24 November 2021
Accepted: 6 November 2021
Abstract Views: 1245
PDF: 755
HTML: 149
HTML: 149
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
A natural compound of marine herbal origin has been used in Persian Traditional Medicine to relieve some symptoms of multiple sclerosis. The present study investigated the anti-inflammatory effects of a patented extracts of the traditional receipt (MS14). In this preliminary experiment, we used seven groups of six rats: the control group received vehicle, the two positive control groups were treated with either sodium salicylate (300 mg/kg) intraperitoneal (i.p.) or methyl prednisolon (MPN 10 mg/kg) i.p., while the test groups were treated with a solution centrifuged MS14 (SANT 100 mg/kg) and suspension of MS14 (SUSP 100, 150, 300 mg/kg) i.p. After thirty minutes, paw volume was measured by plethysmometer and immediately formalin solution was injected subcutaneously into the hind paw and after an hour, inflamed paw volume was measured. In days 2-8, the inflamed paw volume was measured and immediately drugs were injected i.p. The anti-inflammatory effect of MPN was significant only on days 5 and 6. The anti-inflammatory effect of SS was significant only on the 6th day, while the anti-inflammatory effect of SANT MS14 (100 mg/kg) was also significant only on the 6th day. SUSP MS14 (150 mg/kg) significantly reduced edema from second to 6th day. Intra-peritoneal injection of SUSP MS14 with 300 mg/kg was toxic, so excluded from the study. This research indicates that the MS14 possesses an anti-inflammatory effect after intra-peritoneal administration. Comparative anti-inflammatory effects of MS14 with Glucocorticoids in this study, may justify a possible mechanism for its action in multiple sclerosis, if further studies will provid strong statistically confirmatory effects in animals and safety human trials.
Compston A, Coles A. Multiple sclerosis. Lancet. 2008 Oct 25;372(9648):1502-17.
DOI: https://doi.org/10.1016/S0140-6736(08)61620-7
Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Brück W, Parisi JE, Scheithauer BW, Giannini C, Weigand SD, Mandrekar J, Ransohoff RM. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med. 2011 Dec 8;365(23):2188-97.
DOI: https://doi.org/10.1056/NEJMoa1100648
Matthews PM. Chronic inflammation in multiple sclerosis - seeing what was always there. Nat Rev Neurol. 2019 Oct;15(10):582-593.
DOI: https://doi.org/10.1038/s41582-019-0240-y
Kidd PM. Multiple sclerosis, an autoimmune inflammatory disease: prospects for its integrative management. Altern Med Rev. 2001 Dec;6(6):540-66.
Zaffaroni M, Ghezzi A, Comi G. Intensive immunosuppression in multiple sclerosis. Neurol Sci. 2006 Mar;27 Suppl 1:S13-7.
DOI: https://doi.org/10.1007/s10072-006-0539-5
Silbermann E, Senders A, Wooliscroft L, Rice J, Cameron M, Waslo C, Orban A, Chase E, Yadav V, Bourdette D, Spain RI. Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: A 17-Year update. Mult Scler Relat Disord. 2020 Jun;41:102041. Epub 2020 Mar 7.
DOI: https://doi.org/10.1016/j.msard.2020.102041
Crayton HJ, Rossman HS. Managing the symptoms of multiple sclerosis: a multimodal approach. Clin Ther. 2006 Apr;28(4):445-60.
DOI: https://doi.org/10.1016/j.clinthera.2006.04.005
Moosavyzadeh A, Ghaffari F, Mosavat SH, Zargaran A, Mokri A, Faghihzadeh S, Naseri M. The medieval Persian manuscript of Afyunieh: the first individual treatise on the opium and addiction in history. J Integr Med. 2018 Mar;16(2):77-83. Epub 2018 Feb 5.
DOI: https://doi.org/10.1016/j.joim.2018.02.004
Ghaffari F, Naseri M, Jafari Hajati R, Zargaran A. Rhazes, a pioneer in contribution to trials in medical practice. Acta Med Hist Adriat. 2017 Dec;15(2):261-270.
DOI: https://doi.org/10.31952/amha.15.2.4
Babaeian M, Naseri M, Kamalinejad M. The Efficacy of Mentha longifolia in the Treatment of Patients With Postprandial Distress Syndrome: A Double-Blind, Randomized Clinical Trial. Iranian Red Crescent Med J2017;19(2); e34538.
DOI: https://doi.org/10.5812/ircmj.34538
Goshtasebi A, Mazari Z, Behboudi Gandevani S Anti-hemorrhagic activity of Punica granatum L. flower (Persian Golnar) against heavy menstrual bleeding of endometrial origin: A double-blind, randomized controlled trial. Med J Islamic Republic of Iran. 2015; 29:199.
Ansaripour M, Naseri M, Esfahani MM, Nabipour I, Rakhshani F, Zargaran A, Kelishadi R. Periconceptional care and offspring health at birth and long term, from the perspective of Avicenna. J Integr Med. 2019 Mar;17(2):80-86. Epub 2019 Jan 11.
DOI: https://doi.org/10.1016/j.joim.2019.01.003
Nouri F, Zargaran A, Naseri M. Nutrition Therapy in Ancient and Medieval Persia. 2017;19(11): e13716.
DOI: https://doi.org/10.5812/ircmj.13716
Araj-Khodaei M, Noorbala AA, Yarani R, Emadi F, Emaratkar E, Faghihzadeh S, Parsian Z, Alijaniha F, Kamalinejad M, Naseri M. A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with Fluoxetine for the treatment of depression. BMC Complement Med Ther. 2020 Jul 3;20(1):207.
DOI: https://doi.org/10.1186/s12906-020-03003-5
Gorji A. Pharmacological treatment of headache using traditional Persian medicine. Trends Pharmacol Sci. 2003 Jul;24(7):331-4.
DOI: https://doi.org/10.1016/S0165-6147(03)00164-0
Safari MB, Nozad A, Ghaffari F, Ghavamzadeh S, Alijaniha F, Naseri M. Efficacy of a Short-Term Low-Calorie Diet in Overweight and Obese Patients with Chronic Sciatica: A Randomized Controlled Trial. J Altern Complement Med. 2020 Jun;26(6):508-514. Epub 2020 May 20.
DOI: https://doi.org/10.1089/acm.2019.0360
Ghaffari F, Naseri M, Movahhed M, Zargaran A. Spinal Traumas and their Treatments According to Avicenna's Canon of Medicine. World Neurosurg. 2015 Jul;84(1):173-7. Epub 2015 Mar 13.
DOI: https://doi.org/10.1016/j.wneu.2015.03.011
Avicenna. The canon of medicine. Tehran: Soroush Press; 1997.
Hossaini-Tabib M. Tohfe of hakim Momen. Tehran and Qum: Mostafavi Press; 1959. (in Persian).
Aghili M. Makhzan-al-Advia. Tehran: Tehran University of Medical Sciences; 2009: 328.
Hajhashemi V, Ghafghazi T, Ahmadi A. Study the subacute toxicity of natural product MS14 in rat. Daneshvar, 2004; 50:11–14.
Naseri M, Ahmadi A, K Gharegozli K. A double blind, placebo-controlled, crossover study on the effect of MS14, an herbal-marine drug, on quality of life in patients with multiple sclerosis. J Medicinal Plants Res. 2009: 3(4);271-275.
Tafreshi AP, Ahmadi A, Ghaffarpur M, Mostafavi H, Rezaeizadeh H, Minaie B, Faghihzadeh S, Naseri M. An Iranian herbal-marine medicine, MS14, ameliorates experimental allergic encephalomyelitis. Phytother Res. 2008 Aug;22(8):1083-6.
DOI: https://doi.org/10.1002/ptr.2459
Sadeghi AH, Ahmadi A. Cytotoxicity and antitumor properties of a marine compound, HESA-A, on cancer cells. DARU J Pharmaceutical Sci. 2003,11:82-87.
Ojewole JA. Antiinflammatory properties of Hypoxis hemerocallidea corm (African potato) extracts in rats. Methods Find Exp Clin Pharmacol. 2002 Dec;24(10):685-7.
DOI: https://doi.org/10.1358/mf.2002.24.10.802319
Agarwal RB, Rangari VD. Antiinflammatory and Antiarthritic activities of Lupeol and 19 -H Lupeol isolated from strobilanthus callosus and strobilanthus ixiocephala roots. Indian J Pharmacol. 2003; 35: 384-387.
Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977 Dec;4(2):161-174.
DOI: https://doi.org/10.1016/0304-3959(77)90130-0
Ahmadiani A, Javan M, Semnanian S, Barat E, Kamalinejad M. Anti-inflammatory and antipyretic effects of Trigonella foenum-graecum leaves extract in the rat. J Ethnopharmacol. 2001 May;75(2-3):283-6.
DOI: https://doi.org/10.1016/S0378-8741(01)00187-8
Sayyah M, Hadidi N, Kamalinejad M. Analgesic and anti-inflammatory activity of Lactuca sativa seed extract in rats. J Ethnopharmacol. 2004 Jun;92(2-3):325-9.
DOI: https://doi.org/10.1016/j.jep.2004.03.016
Lassmann H. Multiple sclerosis: is there neurodegeneration independent from inflammation? J Neurol Sci. 2007 Aug 15;259(1-2):3-6. Epub 2007 Mar 23.
DOI: https://doi.org/10.1016/j.jns.2006.08.016
Sosa S, Pace R, Bornancin A, Morazzoni P, Riva A, Tubaro A, Della Loggia R. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L. J Pharm Pharmacol. 2007 May;59(5):703-9.
DOI: https://doi.org/10.1211/jpp.59.5.0011
Emad AM, Ali SF, Abdel-Rahman EA, Meselhy MR, Farag MA, Ali SS, Abdel-Sattar EA. Anti-inflammatory and antioxidant effects of Apium graveolens L. extracts mitigate against fatal acetaminophen-induced acute liver toxicity. J Food Biochem. 2020 Jul 26:e13399. Epub ahead of print.
DOI: https://doi.org/10.1111/jfbc.13399
How to Cite
Naseri, M., Rezaeizadeh, H., Mirghazanfari, M., Taheripanah, T., Bararpoor, Z., Ashayeri, N., Asghari, M., Shahi, A. T. M., Emadi, F., Moghaddam, P. M., Nejad, A. H., & Ghaffari, F. (2021). Anti-inflammatory activity of a natural herbal-marine drug (MS14 - SANT and SUSP) compared to sodium salicylate or methylprednisolone in a rat model for multiple sclerosis. European Journal of Translational Myology, 32(1). https://doi.org/10.4081/ejtm.2022.10169
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.